Concepedia

Pharmacogenetic Interventions Improve the Clinical Outcome of Treatment-Resistant Autistic Spectrum Disorder Sufferers

María J. Arranz, Juliana Salazar, V. Bote, Alícia Artigas-Baleri, Alex Serra-Llovich, Emma Triviño, Jordi Roigé, Carlos Lombardia, Martha Cancino, Marta Hernández,

Pharmaceutics · 2022 · 19 citations · 18 references

DOIFull text

Open access

Abstract

The implementation of pharmacogenetic interventions has the potential to significantly improve the clinical outcomes in severe comorbid ASD populations with drug treatment resistance and poor prognosis.

References

18

A Children's Global Assessment Scale (CGAS)

David Shaffer · Archives of General Psychiatry · 1983 · 3.7K citations

The clinical global impressions scale: applying a research tool in clinical practice.

Joan Busner, Steven D. Targum · PubMed · 2007 · 1.8K citations

Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting

Daniel K. Hall‐Flavin, Joel G Winner, Josiah D. Allen et al. · Pharmacogenetics and Genomics · 2013 · 202 citations

Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial

BMC Psychiatry · 2017 · 200 citations · Full text

Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation

Joel G Winner, Joseph Carhart, C. Anthony Altar et al. · Current Medical Research and Opinion · 2015 · 129 citations